AbbVie Pre-Tax Income decreased by 61.1% to $1.04B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 37.4%, from $1.66B to $1.04B. Over 3 years (FY 2021 to FY 2025), Pre-Tax Income shows a downward trend with a -20.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.16B | $3.69B | $4.27B | $4.93B | $1.18B | $4.40B | $2.97B | $475.00M | $2.61B | $1.95B | $1.21B | $1.76B | $2.15B | $2.08B | $1.66B | $1.55B | $714.00M | $2.67B | $1.04B |
| QoQ Change | — | +217.1% | +15.8% | +15.4% | -76.0% | +271.9% | -32.6% | -84.0% | +449.5% | -25.2% | -37.9% | +44.8% | +22.3% | -2.9% | -20.3% | -6.4% | -54.1% | +273.7% | -61.1% |
| YoY Change | — | — | — | — | +1.7% | +19.3% | -30.6% | -90.4% | +120.6% | -55.6% | -59.1% | +269.5% | -17.8% | +6.7% | -5.4% | -27.6% | -65.7% | — | -37.4% |